4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Heart Disease, Ischemic in 1 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yue, P | 1 |
| Lü, YJ | 1 |
| Yang, BF | 1 |
1 review available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Advances in the study of cardiac M3 receptor as a novel target of antiarrhythmic drugs].
Topics: Animals; Delayed Rectifier Potassium Channels; Humans; Membrane Potentials; Myocardial Ischemia; Pil | 2006 |